Lung function abnormalities, including hyperinflation, are common in y
oung children born prematurely. The aim of this study was, in such pat
ients, to determine factors associated with hyperinflation, that is an
elevated lung volume. Lung volume was estimated by measuring function
al residual capacity (FRC) before and after bronchodilator therapy in
41 5-year-old children who had been born prematurely at a median of 30
weeks gestational age. Hyperinflation was defined as an FRC greater t
han 120% of that predicted for height and a positive bronchodilator re
sponse as a greater than or equal to 10% change in FRC. Twelve (29%) o
f the children were symptomatic at 5 years, their median FRC (132%) wa
s significantly higher than that of the asymptomatic children (109%),
P < 0.01. Twelve (29%) children were hyperinflated; a greater proporti
on of the hyperinflated compared to the non-hyperinflated patients wer
e symptomatic at 5 years (7 or 58% versus 5 or 17%) (P < 0.05) and res
ponded to bronchodilator therapy (9 or 75% versus 4 or 14%) (P < 0.01)
. Regression analysis demonstrated that hyperinflation related signifi
cantly only to current symptom status, but not perinatal variables. Co
nclusion Hyperinflation in young children born prematurely reflects cu
rrent symptom status and not adverse neonatal events.